Picture of Guard Therapeutics International AB (publ) logo

GUARD Guard Therapeutics International AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

C2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-40.4-40.3-81.9-115-115
Depreciation
Non-Cash Items0.520.672.83
Other Non-Cash Items
Changes in Working Capital-20.52.163.7912.1-3.81
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-60.6-38-77.6-102-116
Capital Expenditures-0.073
Purchase of Fixed Assets
Other Investing Cash Flow Items0.118000
Sale of Business
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-0.0730.118000
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities10174176113-0.779
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4036.298.612.4-117